We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Plant Health Care Plc | PHC | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.08 | -2.17% | 3.60 | 16:12:26 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.60 | 3.60 | 3.60 | 3.60 | 3.68 |
| Industry Sector |
|---|
| CHEMICALS |
| Top Posts |
|---|
Posted at 24/4/2024 07:42 by cerrito Croda report Q1 crop protection sales down from a very strong Q1 in 2023 and flat on Q4 2023.Have to say never sure if PHC see themselves in crop enhancement or crop protection. |
Posted at 20/4/2024 17:00 by cerrito I see that last year we got the results onApril 12th and the year before on April 28th. They give us s notice of results RNS and a good chance we will get thst this week.Incidentally I went on the news section of the AMVAC website to see if they posted news of the PHC China tie up.They had not and given the size of AMVAC that it no way surprised me. |
Posted at 20/4/2024 16:50 by cerrito Good question slicethepie as to when they get taken out.Industry players appear to have a different view of PHC prospects than Cavendish with their 42p target price and I am a bit uncomfortable that in all these months that the share price has been in the 3's that no-one has come on big to replace Mr Griffiths. My question mark and indeed concern is how Ispraie see this. I have no insight into their level of patience/requirement for liquidity nor indeed of their investors. The mind boggles as to what would happen to he share price if they followed-or tried to follow-Mr Griffiths to the exit door. |
Posted at 17/4/2024 07:45 by robsy2 I am trying to get my head around the investment case for this company so have PHC on my watchlist, am readingthe posts and research with interest.Lots of bumps in the road but the company seems to be making good progress and is about to become profitable yet the share price is at an all time low. With new distribution deals and approvals being announced, could be things are on the move? |
Posted at 16/4/2024 08:24 by cerrito From the way it is worded my reading is that no regulatory approvals are required in China but would have been good to get clarity on this.Confused by the reference to novel as it is good old harpin and my reading is that it is because it is being incorporated into an existing AMVAC product line. I may be wrong but if true could be v exciting. American Vanguard is listed and describes itself as an agriculture and speciality chemical company. Sales and profits declined in 2023 over 2022 and indeed eps declined from 92us cents to 26.It does have a green division.They attributed fall in 2023 sales to our old friend destocking(though said this reversed in q4 calendar 2023), oversupply of Chinese generic products(not a PHC issue) and supply chain problems. |
Posted at 16/4/2024 07:43 by pretax2 There’re no figures on this RNS, but China distribution commencing this year is a huge opportunity for PHC. I look forward to hearing more; also nice to know PHC are alive and kicking. |
Posted at 07/4/2024 18:44 by pretax2 Hi CerritoNot sure how to interpret this (+ve or -ve) as far as PHC is concerned. 1/ "Indigo expanded into too many product areas": PHC have not - they've stuck with Harpin derived peptides. 2/ "Industry of slow adapters": Accepted; but environmental (and supermarket) policy is forcing growers to embrace sustainable growing techniques or lose market share. 3/ "Many of these agtech companies are not ‘tech’ companies, they are simply ‘tech enabled’". ['Tech enabled'?] Harpin is a scientific discovery which has been adapted and enhanced by PHC at its Seattle laboritory. All of the IP belongs to PHC. Somewhat paradoxically, Covid was 'initially' a good thing for PHC (distributors over-stocked), but now a bad thing with the current destocking. This out to be ending around about now so we can get back on the growth path. Time for an update. |
Posted at 07/4/2024 15:31 by cerrito Note there is a US non listed company called Indigo Ag which I heard about reading comments on MNTN whose valuation declined in 2023 from £15.8m to £££800k.The problems in this company were largely self inflicted as they expanded into too many product areas. Last August they launched in the US a bionematicide to fight soybean cyst nematode. Comments about this company’s travails is that they are in an industry of slow adapters and also a comment from an investor that quote “It is investors acknowledging that many of these agtech companies are not ‘tech’ companies, they are simply ‘tech enabled,’ which has a very different multiple of dynamics such as margins and marginal cost structure.unquote Perhaps provides some insight into how PHC-rightly or wrongly-is seen in the US investment community. |
Posted at 09/1/2024 20:42 by pretax2 Concerning fundrasing I asked JT just before Xmas, his response below.------------- ME: Do you still hold the view that no more capital raises are necessary by the company before profits? To do so at the current share-price would be terrible for stockholders. JT: We would prefer not to go back to the market since it would indeed be terrible for shareholders. If additional capital is needed, we are considering several options that will help us get to cash breakeven. ------------- Possibilities might include a bridging loan or issuing sustainable bonds perhaps? The current destocking situation is likely to persist for H1 2024 but new registrations (e.g. Sugar Cane in India) provide the opportunity for PHC to grow their way into profitability. Elsewhere the Brazil PHC field team are going gangbusters promoting Teikko. If they were footballers, they're be in the premier league. Profits can't be too far away now and they have some juicy tax breaks to look forward to once they arrive. |
Posted at 22/11/2023 23:37 by cerrito I woke up Wednesday very long and very wrong on PHC and went to bed even longer and wronger. The key that made me comfortable buying more is that they have no immediate need for funds-their equity raise in June was in retrospect a v good move.I note Cenkos/Cavendish remain comfortable having a positive ebitda next year(good as no interest or tax to pay) , as a result of expense reduction, though I have never had the feeling they have had much fat to cut. We have no info on the profitability of the different geographies. Given their business mix, Mexico profitability per sales is I assume the worst and I go on the basis that NA is more profitable than La as LA more of a start up.Remember NA sales in 2022 were usd 4.8m put of usd11.8m. Cavendish in their note referred to the FMC investor day on November 16 when FMC commented on destocking trends. Specifi Note that FMC talking about the effects of destocking continuing into H1 24. There is however the question that on September 25 in the interims PHC wrote quote With lower inventories and strong customer on-ground sales, we are expecting a strong second half of 2023 with material revenue growth anticipated.unquote. Given today's heavy trading activities with 33m shares traded we await with interest any TR1's.I have to say that in some way with the current msrcap(even if sterling is currently stronger against the dollar than it has been for much of the last year), I would be worried if we did not get a takeover bid as it would suggest that PHC is not undervalued. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
